Evidence map›Paper›PMID 35996282›Full record

Trial reportThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Factors associated with screening failure and study withdrawal in multidrug-resistant TB.

A Schwalb, R Cachay, A Wright, P P J Phillips, P Kaur, A H Diacon, C Ugarte-Gil, C D Mitnick, T R Sterling, E Gotuzzo and 1 more

Abstract readClinical Trial, Phase IIRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

A SchwalbInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
R CachayInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
A WrightVanderbilt University Medical Center, Vanderbilt Tuberculosis Center, Nashville, TN, USA.
P P J PhillipsUniversity of California San Francisco Center for Tuberculosis, San Francisco, CA, USA.
P KaurBoston University, Departments of Epidemiology, Biostatistics, Global Health and Medicine, Boston, MA, USA.
A H DiaconTASK Applied Science and Stellenbosch University, Cape Town, South Africa.
C Ugarte-GilInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
C D MitnickSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
T R SterlingVanderbilt University Medical Center, Vanderbilt Tuberculosis Center, Nashville, TN, USA.
E GotuzzoInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
C R HorsburghBoston University, Departments of Epidemiology, Biostatistics, Global Health and Medicine, Boston, MA, USA.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB TreatmentU01AI100805 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HORSBURGH, CHARLES ROBERT · 2013 to 2016
$5.4M
NIAID NIH HHS P30 AI042853NIAID NIH HHS U01 AI100805
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansLevofloxacinSouth AfricaSputumAntitubercular AgentsLevofloxacin

Identifiers

PMID35996282
PMCPMC13650566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.